Literature DB >> 7955423

Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease.

A C Mann1, C O Record, C H Self, G A Turner.   

Abstract

Liver damage through prolonged intake of high amounts of alcohol is a serious problem that affects many members of the population. The aim of this study was to investigate changes in the glycosylation of haptoglobin (Hp) resulting from alcoholic liver diseases. The monosaccharide composition was measured in Hp isolated from 48 healthy individuals, 15 alcohol abusers (AA); 25 patients with alcoholic liver disease, including those with alcoholic cirrhosis (ALD/AC), and 17 other patients with either chronic active hepatitis (AH) or primary biliary cirrhosis (BC). Fucose was elevated per mol of Hp in 70%, 44%, and 33% of the individuals in the ALD/AC, BC and AA groups, respectively. Fucose was not elevated in the AH group. N-acetylglucosamine was also elevated in the ALD/AC group. Expressing results per 3 mol of mannose suggested the presence of higher branching with increased fucose content in Hp from all the abnormal groups except the AH group. More structural information is required to develop the diagnostic potential of carbohydrate measurements of Hp in alcoholic liver diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955423     DOI: 10.1016/0009-8981(94)90136-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

1.  Glycosylation and over-expression of endometriosis-associated peritoneal haptoglobin.

Authors:  Marta Piva; J Ignacio Moreno; Kathy L Sharpe-Timms
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

2.  Myeloid glycosylation defects lead to a spontaneous common variable immunodeficiency-like condition with associated hemolytic anemia and antilymphocyte autoimmunity.

Authors:  Sean O Ryan; Derek W Abbott; Brian A Cobb
Journal:  J Immunol       Date:  2014-05-02       Impact factor: 5.422

3.  Mgat2 ablation in the myeloid lineage leads to defective glycoantigen T cell responses.

Authors:  Sean O Ryan; Sixto M Leal; Derek W Abbott; Eric Pearlman; Brian A Cobb
Journal:  Glycobiology       Date:  2013-12-04       Impact factor: 4.313

4.  Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients.

Authors:  Gautam Mondal; Urmimala Chatterjee; Yogesh K Chawla; Bishnu Pada Chatterjee
Journal:  Glycoconj J       Date:  2010-12-14       Impact factor: 2.916

Review 5.  Infection, inflammation and host carbohydrates: a Glyco-Evasion Hypothesis.

Authors:  Lori Sc Kreisman; Brian A Cobb
Journal:  Glycobiology       Date:  2012-04-05       Impact factor: 4.313

6.  N-glycans in liver-secreted and immunoglogulin-derived protein fractions.

Authors:  S Bekesova; O Kosti; K B Chandler; J Wu; H L Madej; K C Brown; V Simonyan; R Goldman
Journal:  J Proteomics       Date:  2012-02-03       Impact factor: 4.044

7.  Enhanced expression of alpha1-acid glycoprotein and fucosylation in hepatitis B patients provides an insight into pathogenesis.

Authors:  Gautam Mondal; Urmimala Chatterjee; Hasi R Das; Bishnu P Chatterjee
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

8.  Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.

Authors:  Gautam Mondal; Ashish Saroha; Partha Pratim Bose; B P Chatterjee
Journal:  Glycoconj J       Date:  2016-03-31       Impact factor: 2.916

9.  Alteration of liver glycopatterns during cirrhosis and tumor progression induced by HBV.

Authors:  Yannan Qin; Yaogang Zhong; Tianran Ma; Fei Wu; Haoxiang Wu; Hanjie Yu; Chen Huang; Zheng Li
Journal:  Glycoconj J       Date:  2016-01-30       Impact factor: 2.916

10.  The intrathecal CD163-haptoglobin-hemoglobin scavenging system in subarachnoid hemorrhage.

Authors:  James Galea; Garth Cruickshank; Jessica L Teeling; Delphine Boche; Patrick Garland; V Hugh Perry; Ian Galea
Journal:  J Neurochem       Date:  2012-03-30       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.